Good article on F & P. Healthcare. http://i.stuff.co.nz:80/business/ind...ettle-above-10
disc. Holding
Printable View
Good article on F & P. Healthcare. http://i.stuff.co.nz:80/business/ind...ettle-above-10
disc. Holding
I think the last two paragraphs or so where the most notable
https://nzx.com/companies/FPH/announcements/283077
Continuing to snooze its way up hopefully.
Optiflow™ nasal high flow therapy is a real winner. $50 + per patient consumables, and we are using it more and more. Keeping patients off ventilators and BIPAP, and used on anyone who needs oxygen for more that 3 hrs . ... that's a lot of patients . its not been around long so its growth could be outstanding. It cost $NZ 3500 a day to keep a patient in ICU, so this device keeps patents off ventilators and adds to FPH's bottom line. win-win :-)
Great result,great outlook :)
Good result, maybe revenue missed consensus of $822 million.
Am working on a DCF model for FPH, believe this may be fundamentally overvalued at the moment. Will publish once complete (Capex modelling at the moment!)
I think the prospects of the company are good, but investors may be paying a bit of a premium for that at this stage.
double digits growth next year as well
Outstanding result.